Literature DB >> 12202991

A novel splice variant of the cell adhesion molecule contactin 4 ( CNTN4) is mainly expressed in human brain.

Li Zeng1, Chengzhi Zhang, Jian Xu, Xin Ye, Qihan Wu, Jianfeng Dai, Chaoneng Ji, Shaohua Gu, Yi Xie, Yumin Mao.   

Abstract

Axon-associated cell adhesion molecules (AxCAMs) of the immunoglobulin superfamily play important roles in the formation, maintenance, and plasticity of functional neuronal networks. Contactin4 ( CNTN4, BIG-2) is a member of the TAG-1/F3 subgroup of AxCAMs. We have cloned a novel splice variant of CNTN4, and term it CNTN4A. The complete nucleotide sequence of CNTN4 is also obtained by combining the insert sequences of two clones, which were isolated when screening the human fetal brain cDNA library with CNTN4A as a probe. CNTN4A protein has an N-terminal cleavable signal peptide, two FNIII-like domains, and a glycosyl phosphatidylinositol-anchoring domain. According to the search of the human genome database, CNTN4 was mapped to 3p25-26, a region very close to the breakpoints of the 3p syndrome. Expression analysis of CNTN4A shows that CNTN4A is mainly expressed in brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202991     DOI: 10.1007/s100380200073

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  8 in total

Review 1.  Contactins: emerging key roles in the development and function of the nervous system.

Authors:  Yasushi Shimoda; Kazutada Watanabe
Journal:  Cell Adh Migr       Date:  2009-01-06       Impact factor: 3.405

2.  Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome.

Authors:  Thomas Fernandez; Thomas Morgan; Nicole Davis; Ami Klin; Ashley Morris; Anita Farhi; Richard P Lifton; Matthew W State
Journal:  Am J Hum Genet       Date:  2004-04-21       Impact factor: 11.025

3.  Genetics of variation in serum uric acid and cardiovascular risk factors in Mexican Americans.

Authors:  V Saroja Voruganti; Subrata D Nath; Shelley A Cole; Farook Thameem; Jeremy B Jowett; Richard Bauer; Jean W MacCluer; John Blangero; Anthony G Comuzzie; Hanna E Abboud; Nedal H Arar
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

4.  Nanomechanics of Ig-like domains of human contactin (BIG-2).

Authors:  Karolina Mikulska; Lukasz Pepłowski; Wiesław Nowak
Journal:  J Mol Model       Date:  2011-03-29       Impact factor: 1.810

5.  Effect of the Minor C Allele of CNTN4 rs2619566 on Medial Hypothalamic Connectivity in Early-Stage Patients of Chinese Han Ancestry with Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Yao Wang; Yujie He; Yanyan Zhu; Ting He; Jie Xu; Qinmei Kuang; Yuqi Ji; Renshi Xu; Fangjun Li; Fuqing Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2022-02-25       Impact factor: 2.570

6.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Bin Yao; Susan Land; Diane Studzinski
Journal:  J Neuroinflammation       Date:  2007-12-18       Impact factor: 8.322

7.  Cntn6 deficiency impairs allocentric navigation in mice.

Authors:  Di Mu; Yiliang Xu; Tian Zhao; Kazutada Watanabe; Zhi-Cheng Xiao; Haihong Ye
Journal:  Brain Behav       Date:  2018-04-20       Impact factor: 2.708

8.  Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer's disease.

Authors:  Giulia Monti; Mads Kjolby; Anne Mette G Jensen; Mariet Allen; Juliane Reiche; Peter L Møller; Raquel Comaposada-Baró; Bartlomiej E Zolkowski; Cármen Vieira; Margarita Melnikova Jørgensen; Ida E Holm; Paul N Valdmanis; Niels Wellner; Christian B Vægter; Sarah J Lincoln; Anders Nykjær; Nilüfer Ertekin-Taner; Jessica E Young; Mette Nyegaard; Olav M Andersen
Journal:  Acta Neuropathol Commun       Date:  2021-03-16       Impact factor: 7.578

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.